Large Cap

Large Cap
Pharmaceuticals
Trade Of The Day

Bristol-Myers Squibb Company (BMY) Is Breaking Out

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. BMY $78.6100 0.9200 % 1.1800 Bristol-Myers Squibb Company Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 1.18% Wk: 6.4% […]

Read More
Aerospace
AirCraft
Airlines
Cash
Coronavirus
COVID-19
Defense Stocks
Dividend Stocks
Dividend Yields
Dividends
Fibonacci Retracement
Free Cash Flow
Fundamental Analysis
Fundamentals
Interest Rates
InvestivDaily
Large Cap
Rising Interest Rates
Technical Analysis
Transportation
Travel
Valuations
Value Investing

RTX is nearing its 52-week high – could it go higher?

One of the big recovery stories over the past year has come from the Aerospace industry, which includes commercial airlines. It really comes as no surprise to say that in 2020 and the early part of 2021 the industry was one of the biggest, unquestioned losers in the stock market after commercial travel dried up […]

Read More
Biopharmaceuticals
Biotech
COVID-19
Dividend Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Immunology Biopharmaceutical
InvestivDaily
Large Cap
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing

JNJ is stabilizing after dropping off a 52-week high – is it a good buy?

Years ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]

Read More
Large Cap
Tech Stocks

Big Tech’s Stocks Have Bounced Back. But They’re Not Out of The Woods.

Photo by JOSH EDELSON/AFP via Getty Images The stocks of the five biggest tech companies have mostly recovered from their sharp drop earlier this week, but that doesn’t mean they’re out of the woods. Facebook (FB) plunged nearly 5% on Monday after a whistleblower went public with internal documents and three of its social media […]

Read More

  

X